Details of the Drug-Related molecule(s) Interaction Atlas

Aryl carboxamide derivative 1 Drug Info

PMID25539043-Compound-WO2010137351Example37

Cross-matching ID

TTD Drug ID

DMTZRCW

General Information of Drug (ID: DMTZRCW)

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Approved Drug(s)

Patented Agent(s)

Discontinued Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Voltage-gated sodium channel alpha Nav1.7 (SCN9A)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
XEN-402	DMR69CG	Osteoarthritis	FA00-FA05	Phase 2	[2]
PF-05089771	DMD74BJ	Chronic pain	MG30	Phase 2	[3]
BIIB074	DMLV1ET	Bipolar disorder	6A60	Phase 2	[4]
DSP-2230	DM0WTMD	Neuropathic pain	8E43.0	Phase 1	[4]
BIIB095	DMUC6EP	Pain	MG30-MG3Z	Phase 1	[4]
GDC0310	DMUNFEP	Chronic pain	MG30	Phase 1	[5]
DSP-3905	DMYHU24	Neuropathic pain	8E43.0	Phase 1	[4]
PF-05241328	DM2NTBL	Pain	MG30-MG3Z	Phase 1	[6]
DWJ-208	DMQKDJZ	Cancer related pain	MG30	Phase 1	[4]
RG7893	DM1R4MQ	Pain	MG30-MG3Z	Phase 1	[7]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Drug(s) Targeting Voltage-gated sodium channel alpha Nav1.5 (SCN5A)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Mephenytoin	DM5UGDK	Epilepsy	8A60-8A68	Approved	[8]
Mexiletine	DMCTE9R	Ventricular tachycardia	BC71	Approved	[9]
Fosphenytoin	DMOX3LB	Epilepsy	8A60-8A68	Approved	[8]
Disopyramide	DM5SYZP	Long QT syndrome	BC65.0	Approved	[9]
LOMERIZINE	DME0TC8	Migraine	8A80	Approved	[10]
Tetrodotoxin	DMWMPRG	Bacterial infection	1A00-1C4Z	Approved	[11]
Dyclonine	DMU6OFP	Pain	MG30-MG3Z	Approved	[12]
Moricizine	DMOMBJW	Arrhythmia	BC9Z	Approved	[13]
Ethotoin	DMXWOCP	Complex partial seizure	8A68.0	Approved	[14]
Prilocaine	DMI7DZ2	Pain	MG30-MG3Z	Approved	[12]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Drug(s) Targeting Voltage-gated sodium channel alpha Nav1.3 (SCN3A)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
LIDOFLAZINE	DMV23GL	Angina pectoris	BA40	Approved	[15]
Aryl carboxamide derivative 2	DM146TA	N. A.	N. A.	Patented	[1]
Pyrimidine derivative 1	DMN9VQM	N. A.	N. A.	Patented	[1]
Pyrrolo-pyridinone derivative 6	DMXGNP8	N. A.	N. A.	Patented	[1]
Pyrrolo-pyridinone derivative 5	DMK2FSY	N. A.	N. A.	Patented	[1]
SIPATRIGINE	DMMQ4GC	Neurological disorder	6B60	Discontinued in Phase 2	[16]
U-92032	DMTYO3P	N. A.	N. A.	Terminated	[17]
PD-85639	DMNUKB4	N. A.	N. A.	Terminated	[15]
batrachotoxin	DMYH9SU	Discovery agent	N.A.	Investigative	[18]
veratridine	DMUF8JZ	Discovery agent	N.A.	Investigative	[18]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Voltage-gated sodium channel alpha Nav1.3 (SCN3A)	TTAXZ0K	SCN3A_HUMAN	Inhibitor	[1]
Voltage-gated sodium channel alpha Nav1.5 (SCN5A)	TTZOVE0	SCN5A_HUMAN	Inhibitor	[1]
Voltage-gated sodium channel alpha Nav1.7 (SCN9A)	TT4G2JS	SCN9A_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	Sodium channel blockers: a patent review (2010 - 2014).Expert Opin Ther Pat. 2015 Mar;25(3):279-90.
2	Treatment of Na(v)1.7-mediated pain in inherited erythromelalgia using a novel sodium channel blocker. Pain. 2012 Jan;153(1):80-5.
3	Primary erythromelalgia: a review. Orphanet J Rare Dis. 2015 Sep 30;10:127.
4	Antibodies and venom peptides: new modalities for ion channels. Nat Rev Drug Discov. 2019 May;18(5):339-357.
5	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
6	Recent progress in sodium channel modulators for pain. Bioorg Med Chem Lett. 2014 Aug 15;24(16):3690-9.
7	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800041740)
8	Lacosamide: a new approach to target voltage-gated sodium currents in epileptic disorders. CNS Drugs. 2009;23(7):555-68.
9	Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. J Cardiovasc Electrophysiol. 2000 Dec;11(12):1320-9.
10	Medicinal chemistry of neuronal voltage-gated sodium channel blockers. J Med Chem. 2001 Jan 18;44(2):115-37.
11	Halothane attenuates the cerebroprotective action of several Na+ and Ca2+ channel blockers via reversal of their ion channel blockade. Eur J Pharmacol. 2002 Oct 4;452(2):175-81.
12	Monoamine transporter and sodium channel mechanisms in the rapid pressor response to cocaine. Pharmacol Biochem Behav. 1998 Feb;59(2):305-12.
13	From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials. Am J Cardiol. 1996 Aug 29;78(4A):28-33.
14	How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
15	Synthesis and pharmacological evaluation of phenylacetamides as sodium-channel blockers. J Med Chem. 1994 Jan 21;37(2):268-74.
16	Synthesis and structure-activity relationships of 6,7-benzomorphan derivatives as use-dependent sodium channel blockers for the treatment of stroke. J Med Chem. 2002 Aug 15;45(17):3755-64.
17	Discovery of (2S)-1-(4-amino-2,3,5- trimethylphenoxy)-3-[4-[4-(4- fluorobenzyl)phenyl]-1-piperazinyl]-2-propanol dimethanesulfonate (SUN N8075): a ... J Med Chem. 2000 Sep 7;43(18):3372-6.
18	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 580).